July 27, 2021 • 1:30 PM - 2:30 PM ET
As the country continues to grapple with Covid-19 and adjusts to a new Administration, stakeholders across the health care sector will restart discussions about how to ensure sustainability and affordability. Inevitably, these conversations will thrust the longstanding priority of cancer care back into the spotlight. Oncology leaders and providers must establish sustainable growth strategies amid growing payer pressures, changing consumer/patient expectations, and quickly evolving clinical and competitive landscapes - all while managing the continued impact of the pandemic. During this panel, discuss how life sciences firms are partnering with their provider customers in different-in-kind ways to navigate the challenges of the current environment while preparing for future success. Specifically, hear how suppliers and providers are working together to:
- Respond to growing pressures to control oncology costs
- Implement and adopt innovative treatments
- Ensure access, adherence, and symptom/side-effect management for patients
- Improve health equity in oncology